Health Products

Lactate Dehydrogenase L-P (LDH) (NAD) (2020-08-15)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
523902
Manufacturer
Randox Laboratories Ltd.
55 Diamond Road
Crumlin, County Antrim
BT29 4QY
UNITED KINGDOM
Lactate Dehydrogenase L-P (LDH) (NAD)LD3842

Introduction

Affected Products

Lactate Dehydrogenase L-P (LDH) (NAD)

Reason

Randox have released an update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate dehydrogenase assay on Rx instruments. Additional pipette washes can be implemented as described in the technical bulletin.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime